申请人:Bristol-Myers Squibb Company
公开号:US08349880B2
公开(公告)日:2013-01-08
The present disclosure provides a series of compounds of the formula (I)
which reduce β-amyloid peptide (β-AP) production and are useful in the treatment of Alzheimer's Disease and other conditions affected by β-amyloid peptide (β-AP) production.
本公开提供了一系列式(I)的化合物,可减少β淀粉样肽(β-AP)的产生,并可用于治疗阿尔茨海默病和其他受β淀粉样肽(β-AP)产生影响的疾病。